CRM1 Enhances the Lentiviral Vector Production

被引：0
|
作者：
Lo, Hsin-Lung [1 ]
Chang, Tammy [1 ]
Marcovecchio, Paola M. [1 ]
Yam, Priscilla [1 ]
Zaia, John A. [1 ]
Yee, Jiing-Kuan [1 ]
机构：
[1] City Hope Natl Med Ctr, Beckman Res Inst, Duarte, CA 91010 USA
来源：
MOLECULAR THERAPY | 2006年 / 13卷
关键词：
D O I：
10.1016/j.ymthe.2006.08.429
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
370
引用
收藏
页码：S141 / S141
页数：1
相关论文
共 50 条
  • [1] Differential interaction between human and murine Crm1 and lentiviral Rev proteins
    Yue, Yan
    Coskun, Ayse K.
    Jawanda, Navneet
    Auer, Jim
    Sutton, Richard E.
    VIROLOGY, 2018, 513 : 1 - 10
  • [2] CBS9106 is a novel reversible oral CRM1 inhibitor with CRM1 degrading activity
    Sakakibara, Keiichi
    Saito, Naoya
    Sato, Takuji
    Suzuki, Atsushi
    Hasegawa, Yoko
    Friedman, Jonathan M.
    Kufe, Donald W.
    VonHoff, Daniel D.
    Iwami, Tadahiko
    Kawabe, Takumi
    BLOOD, 2011, 118 (14) : 3922 - 3931
  • [3] CRM1 Inhibitors for Antiviral Therapy
    Mathew, Cynthia
    Ghildyal, Reena
    FRONTIERS IN MICROBIOLOGY, 2017, 8
  • [4] Small Molecule Inhibitors of CRM1
    Ferreira, Bibiana I.
    Cautain, Bastien
    Grenho, Ines
    Link, Wolfgang
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [5] RanBP3 enhances nuclear export of active β-catenin independently of CRM1
    Hendriksen, J
    Fagotto, F
    van der Velde, H
    van Schie, M
    Noordermeer, J
    Fornerod, M
    JOURNAL OF CELL BIOLOGY, 2005, 171 (05): : 785 - 797
  • [6] THE ROLE OF CRM1 DIMERIZATION IN CRM1-AF10 LEUKEMOGENESIS
    Aumann, Waitman
    Kim, Sei Gyung
    Lavau, Catherine
    Wechsler, Daniel
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S11 - S11
  • [7] CBS9106 is a novel low toxic reversible oral CRM1 inhibitor with CRM1 degrading activity
    Sakakibara, Keiichi
    Saito, Naoya
    Sato, Takuji
    Suzuki, Atsushi
    Hasegawa, Yoko
    Friedman, Jonathan M.
    Suganuma, Masashi
    Kufe, Donald W.
    VanHoff, Daniel D.
    Iwami, Tadahiko
    Kawabe, Takumi
    CANCER RESEARCH, 2011, 71
  • [8] Prognostic value of CRM1 in pancreas cancer
    Huang, Wei-yi
    Yue, Lu
    Qiu, Wen-shen
    Wang, Li-wei
    Zhou, Xiao-han
    Sun, Yuan-jue
    CLINICAL AND INVESTIGATIVE MEDICINE, 2009, 32 (06): : E315 - E321
  • [9] Therapeutic targeting of CRM1 in ovarian cancer
    Miyake, Takahito M.
    Pradeep, Sunila
    Zand, Behrouz
    Dalton, Heather J.
    Wen, Yunfei
    Pena, Guillermo N. Armaitz
    Kauffman, Michael
    McCauley, Dilara
    Shacham, Sharon
    Wiktorowicz, John E.
    Sood, Anil K.
    CANCER RESEARCH, 2013, 73 (08)
  • [10] Characterizing the Role of CRM1 in Gene Delivery
    Rahmani, K.
    Badding, M. A.
    Lapek, J. D.
    Friedman, A. E.
    Dean, D. A.
    MOLECULAR BIOLOGY OF THE CELL, 2013, 24
12345